[KongchangAI]
Company

Proximal Ventures

An early-stage venture capital fund focused on AI-driven drug discovery, founded by former SignalFire investor Sahir Raoof. It invests from seed through Series A, concentrating on startups that bring artificial intelligence into the pharmaceutical R&D process.

Timeline (last 90 days)

Nov 10

Proximal Ventures has completed the raising of its first fund, amounting to $27.5 million.

Unverified50%
Nov 10

Proximal Ventures was founded by former SignalFire investor Sahir Raoof.

Unverified50%
Nov 10

Proximal Ventures' first fund explicitly focuses on startups that bring artificial intelligence into the drug discovery process.

Unverified50%
Nov 10

A fund size of $27.5 million is typical for an early-stage fund at the intersection of biotech and AI, usually corresponding to checks at the seed to Series A stage.

Unverified50%
Nov 10

Proximal Ventures' entry shows that capital is still willing to bet at an early stage on vertical-domain AI applications rather than generalized AI platforms.

Unverified50%
Nov 10

Whether Raoof's experience at SignalFire accumulated sufficient biopharmaceutical industry resources is limited in currently public information, and this will be a key variable in evaluating the fund's subsequent performance.

Unverified50%

All Facts (6)

Source Articles